News

Fierce Pharma57m
Bayer scores first approval for hormone-free menopause drug Lynkuet in UK
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
Precision Medicine Online22m
Researchers in Australia Explore Potential of New CRISPR-Edited CAR T-Cell Therapy in Solid Tumors
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...